Literature DB >> 11509916

CIBIS, MERIT-HF, and COPERNICUS trial outcomes: do they complete the chapter on beta-adrenergic blockers as antiarrhythmic and antifibrillatory drugs?

B N Singh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509916     DOI: 10.1177/107424840100600201

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


× No keyword cloud information.
  1 in total

1.  Nebivolol therapy improves QTc and QTcd parameters in heart failure patients.

Authors:  S M Aksoy; S Cay; G Cagirci; N Sen
Journal:  Cardiovasc J Afr       Date:  2012-05       Impact factor: 1.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.